scispace - formally typeset
X

Xu Zhao

Researcher at Chinese Ministry of Education

Publications -  12
Citations -  266

Xu Zhao is an academic researcher from Chinese Ministry of Education. The author has contributed to research in topics: Lipid metabolism & Medicine. The author has an hindex of 7, co-authored 9 publications receiving 159 citations. Previous affiliations of Xu Zhao include Central South University.

Papers
More filters
Journal ArticleDOI

The implications of signaling lipids in cancer metastasis.

TL;DR: Signaling lipids implicated in cancer migration, invasion and metastasis, the regulatory signaling hubs of lipid anabolic and catabolic metabolism, and the lipid composition of exosomes budded off from tumor cells are described.
Journal ArticleDOI

DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma

TL;DR: This work establishes a mechanistic connection between epigenetics and metabolism in EBV-positive NPC and provides further evidence for pathological classification based on CpG island methylator phenotype (CIMP) inEBV-associated malignancies.
Journal ArticleDOI

Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases.

TL;DR: Alkaloid and polyphenol are promising candidates for metabolic diseases to ameliorate lipid metabolism abnormalities to improve or even curing lipid metabolism-related diseases.
Journal ArticleDOI

Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer

TL;DR: This review describes the regulatory machinery of lipid metabolism and its deregulation in metabolic diseases and enumerates and integrates the mechanism of action of some natural compounds, including terpenoids and flavonoids, to ameliorate the development of metabolic diseases by targeting lipid metabolism.
Journal ArticleDOI

DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma.

TL;DR: It is demonstrated that TCN is able to induce growth inhibition of NPC in vitro and in vivo by up-regulating DHRS2, and may be a target for the development of targeted therapies against NPC.